Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice  by Bird, J. Eileen et al.
Kidney International, Vol. 57 (2000), pp. 129–136
Increased severity of glomerulonephritis in C-C chemokine
receptor 2 knockout mice
J. EILEEN BIRD, MARY R. GIANCARLI, TAKAO KURIHARA, MARK C. KOWALA,
MARIA T. VALENTINE, PETER H. GITLITZ, DARSHANA G. PANDYA, MICHELE H. FRENCH,
and STEPHEN K. DURHAM
Division of Metabolic and Cardiovascular Drug Discovery, Toxicology, and Lead Safety Assessment, Bristol-Myers Squibb,
Princeton, New Jersey, and Kimeragen, Newtown, Pennsylvania, USA
injury was more severe in nephritic CCR2 knockout mice thanIncreased severity of glomerulonephritis in C-C chemokine
nephritic wild-type mice on day 4 (3.1 6 0.3 vs. 2.0 6 0.3) andreceptor 2 knockout mice.
day 7 (3.6 6 0.2 vs. 2.9 6 0.3). By immunohistochemical analysisBackground. The C-C chemokine receptor 2 (CCR2) is ex-
at day 4, there were significantly fewer mac-2–positive cells,pressed on monocytes and facilitates monocyte migration.
representative of macrophages in the glomeruli of nephriticCCR2 is a prominent receptor for monocyte chemoattractant
protein-1 (MCP-1). This chemokine recruits monocytes to sites CCR2 knockout (2.1 6 0.6) mice than nephritic wild-type
of inflammation. It has been suggested that CCR2 and its li- (3.9 6 0.5) animals. By indirect immunofluorescence, there
gand, MCP-1, play a role in the pathogenesis of glomerulone- was a moderate, diffuse linear IgG deposition of equivalent
phritis. The goal of this study was to determine the contribution severity present in glomeruli of both wild-type and CCR2
of CCR2 in a murine model of accelerated nephrotoxic nephri- knockout nephritic mice.
tis. We measured the extent of development of renal disease Conclusion. These results suggest that our strategy was suc-
in CCR2 wild-type and knockout mice after the administration cessful in reducing macrophage infiltration, but this model of
of antiglomerular basement membrane antibody. glomerulonephritis is not solely dependent on the presence of
Methods. Eight groups of animals were treated (N 5 10 per CCR2 for progression of disease. After a transient ameliorative
group). Four days after IgG immunization, CCR2 wild-type effect on proteinuria, CCR2 knockout led to more severe injury
and knockout mice received control serum or nephrotoxic se- in nephritic mice. This raises the intriguing possibility that
rum. The urinary protein/creatinine ratio was measured on a CCR2 gene product ameliorates glomerulonephritis in this
days 1 and 3; plasma and kidneys were collected on days 4 and murine model. Although effects that occur in chemokine
7. Kidneys were evaluated by light microscopy, immunohisto- knockout mice are not equivalent to those expected with pro-
chemistry, and immunofluorescence. The genotype of mice was longed use of a chemokine antagonist, this study may neverthe-
confirmed by tissue analysis. less have implications for consideration of long-term use of
Results. Protective effects of CCR2 knockout on the urinary chemokine antagonists in renal disease.
protein/creatinine ratio were observed on day 1, as values for
this parameter were significantly lower (35 6 3.6) than in ne-
phritic wild-type mice (50 6 6.8). There was a marked increase
in proteinuria in nephritic wild-type mice on day 1 compared C-C chemokine receptor 2 (CCR2) is expressed by
with vehicle-treated, wild-type animals (5 6 1.0). On day 3, monocytes and is a prominent receptor for monocyte
the ameliorative effects of CCR2 knockout were not observed; chemoattractant protein-1 (MCP-1) and MCP-3 [1, 2].the increase in the urinary protein/creatinine ratio was similar
CCR2 is expressed in normal mouse kidney and is up-in nephritic CCR2 wild-type (92 6 11.2) and knockout mice
(102 6 9.2). Plasma markers of disease were evaluated on days regulated in glomerulonephritis (abstract; Schadde et al,
4 and 7. At these time points, there were no beneficial effects J Am Soc Nephrol 8:485A, 1997). MCP-1 is a potent
of CCR2 receptor knockout on plasma levels of urea nitrogen, agonist for mononuclear leukocytes and is produced bycreatinine, albumin, or cholesterol. On day 7, blood urea nitro-
multiple renal cells, including mesangial cells, epithelialgen (248 6 19.9 mg/dL) and plasma cholesterol were higher
cells, and endothelial cells. Renal expression of MCP-1in nephritic CCR2 knockout mice than in wild-type mice (142 6
41.7 mg/dL) that received nephrotoxic serum. Histopathologic was reviewed by Luckow, Wolf, and Schlondorff [3]. This
chemokine recruits monocytes to sites of inflammation
[4, 5]. It has been suggested that CCR2 and its ligand,Key words: chemokines, monocyte chemoattractant protein-1, nephro-
toxic nephritis, inflammation. MCP-1, play a role in the pathogenesis of glomerulone-
phritis. For example, glomerular expression of MCP-1
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lated with the influx of macrophages [7]. In addition, and kept frozen (2208C) until needed. Animals were
sacrificed on day 4 or day 7.administration of anti–MCP-1 monoclonal antibody sig-
On days 1 and 3, spot urine samples were collectednificantly suppressed glomerular monocyte/macrophage
and analyzed for protein and creatinine. Protein wasinfiltration and reduced urinary protein excretion in rats
quantitated using the Coomassie Brilliant Blue systemtreated with nephrotoxic serum [8].
(QuanTtest Blue Total Protein Assay System; Quan-The increased expression of MCP-1 in several disease
timetrix Corp., Redondo Beach, CA, USA) adapted tostates has supported the theory that MCP-1 and its pri-
the Abbott ABA-100 Bichromatic Analyzer (Abbott Di-mary receptor, CCR2, are responsible for the inflamma-
agnostics, Abbott Park, IL, USA). On day 4, one set oftory component of these diseases. An association has
mice was weighed and anesthetized with sodium pento-been demonstrated but not a causal relationship, as the
barbital (100 mg/kg, intraperitoneally), and blood waslatter requires inhibitors or gene knockout of MCP-1 or
collected from the orbital sinus. The left kidney wasits receptor. CCR2 knockout mice have been generated
removed, cut in half in cross section, and immersion fixedin several laboratories [9–11]. Studies have demonstrated
in 10% neutral-buffered formalin for light microscopicthat CCR2 knockout mice failed to recruit macrophages
examination.in a peritoneal inflammation model [9] and displayed
On day 7, the second set of mice was weighed andreduced monocyte migration [10]. We used CCR2
anesthetized, and tissues and blood were collected asknockout mice in this study to evaluate the contribution
described earlier in this article. Plasma samples wereof CCR2 to the pathogenesis of accelerated nephrotoxic
analyzed for albumin, urea nitrogen, creatinine, and totalnephritis.
cholesterol using the Boehringer Mannheim/Hitachi 717
Analyzer (Boehringer Mannheim Corp., Indianapolis,
METHODS IN, USA). Albumin was analyzed using Liquid-STAT
Albumin Reagent (Beckman Instruments, Inc., Brea,The procedures followed were in accordance with ani-
CA, USA). Blood urea nitrogen (BUN) was analyzedmal-use guidelines of Bristol-Myers Squibb (Princeton,
using BUN System Pack (Boehringer Mannheim Corp.).NJ, USA). CCR2 wild-type and knockout mice were
Creatinine was analyzed using Creatinine System Packgenerated at Bristol-Myers Squibb [8]. The CCR2 gene
(Boehringer Mannheim Corp.). Cholesterol was ana-was targeted in embryonic stem cells derived from
lyzed using Total Serum Cholesterol (Diagnostic Chemi-129/Sv mice. These cells were then aggregated with mor-
cals Limited, Oxford, CT, USA).ula derived from ICR mice in order to generate the
CCR2 knockout mice. Thus, the knockout mice have a Polymerase chain reaction
mixed genetic background of 129/Sv and ICR. The wild-
The genotype of mice was confirmed by polymerasetype and knockout mice used in this study were derived
chain reaction (PCR). Tail tissue from wild-type andfrom crosses of heterozygous littermates and were of a
knockout mice was digested in PCR buffer containing
hybrid 129/Sv:ICR background.
nonionic detergents with proteinase K for four hours at
Pups were weaned at 21 days, separated according to 558C with occasional vortexing. Samples were heated
gender, weighed, and identified by a transponder placed to 958C for 10 minutes and centrifuged for 5 minutes.
under the skin. A 0.75 cm piece of tail was obtained The supernatant was used as a template and analyzed
and frozen in liquid nitrogen for subsequent analysis of by PCR.
genotype. Polymerase chain reaction was carried out using two
At five weeks of age, mice were immunized by an pairs of oligonucleotides in a multiplexed reaction. The
intraperitoneal injection of 0.25 mg sheep IgG (Sigma first pair of oligonucleotides was specific for CCR2, am-
Chemical Co., St. Louis, MO, USA) in 250 mL phos- plifying a 320 bp fragment (59-TGG TAA ATT CTT
phate-buffered saline emulsified with an equal volume CAG GCT TTC C-39 and 59-TCC ACA ACC TGA
of complete Freund’s adjuvant (GIBCO BRL Products, TAA AGC CTC C-39). The second pair of oligonucleo-
Gaithersburg, MD, USA). On day 0, four days after IgG tides amplified a 220 bp fragment of the Neo cassette,
immunization, sheep serum (Sigma) or 100 mL of sheep used as a positive control (59-CGG CCA CAG TCG
antirat glomerular basement membrane (GBM) nephro- ATG AAT CCA GAA A-39 and 59-CCA TTC GAC
toxic serum (a generous gift from Dr. Karen Munger, CAC CAA GCG AAA CAT C-39). In a total of 30 mL,
Emory University, Atlanta, GA, USA) was administered the reaction mixture contained 20.0 mL milliQ water, 3.0
via a lateral tail vein to wild-type and knockout mice mL 10 3 PCR buffer (Perkin Elmer, Foster City, CA,
(N 5 10 per group). Serum was diluted in phosphate- USA), 1.2 mL dNTPs (2.5 mmol/L), 2.0 mL oligonucleo-
buffered saline so that each mouse received a total vol- tides, 0.3 mL Perfect Match (Stratagene, La Jolla, CA,
ume of 150 mL. Both nephotoxic serum and sheep serum USA), 2.5 units Taq DNA polymerase (Perkin Elmer),
and 3.0 mL template. PCR was carried out using a Mini-were heat inactivated by heating to 568C for 45 minutes
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cycler PCR system (MJ Research, Watertown, MA,
USA) starting at 948C for two minutes, then 948C for one
minute, 608C for 1.5 minutes, and 728C for one minute for
25 cycles. The resulting reaction products were analyzed
by gel electrophoresis (2% agarose) using a 100 bp ladder
(GIBCO BRL) as a size marker.
Histopathology, immunohistochemistry,
and immunofluorescence
Kidneys were embedded in paraffin, sectioned at 3
mm, stained with periodic acid-Schiff (PAS), and graded
by light microscopy without knowledge of the treatment.
The glomerular changes were graded as to the severity
of injury: grade 0, normal; grade 1, minimal mesangial
expansion; grade 2, mild increase in mesangial matrix,
segmental in nature and involving less than 50% of the
glomerular tuft; grade 3, moderate increase in mesangial
Fig. 1. Effects of CCR2 knockout in nephritic mice on the urinarymatrix that involves greater than 50% of the glomerular
protein/creatinine ratio. Data are mean 6 sem. *P , 0.05 vs. vehicletuft; and grade 4, marked increase in mesangial matrix
wild-type (WT); #P , 0.05 vs. nephritic (NTS) WT. Symbols are: (j)
resulting in tuft obliteration. vehicle WT; ( ) vehicle knockout (KO); ( ) NTS WT; ( ) NTS KO.
Paraffin-embedded kidneys were immunohistochemi-
cally analyzed using the rat antimouse antibody (1:1000)
directed against the macrophage marker mac-2 (Ce-
creatinine ratio was similar in the two groups of micedarlane, Ontario, Canada). The number of mac-2–
that received nephrotoxic serum.positive cells in 20 randomly selected glomeruli from
Plasma markers of disease were evaluated on days 4
each animal was enumerated and expressed as a mean.
and 7, and no beneficial effects of CCR2 knockout in
Indirect immunofluorescence was performed on de- nephritic mice were observed. In fact, BUN values were
paraffinized formalin-fixed kidneys after antigen un- significantly higher in CCR2 knockout mice (111 6 22.8
masking using 0.1% protease digestion. Biotinylated mg/dL) on day 4 than in control wild-type mice (25 6
goat antimouse IgG (1:50; Vector Laboratories, Burl- 1.0 mg/dL) and were also higher on day 7 than in ne-
ingame, CA, USA) was followed by streptavadin-fluo- phritic wild-type mice, suggesting more severe injury in
rescein isothiocyanate (1:50; Dako, Carpinteria, CA, the nephritic knockout mice (Fig. 2). Levels of this pa-
USA) for 30 minutes at 258C. Mice treated with heat- rameter were not increased in vehicle-treated CCR2
inactivated sheep serum, and duplicate samples from knockout mice.
nephritic mice with omission of the primary antibody As with BUN, plasma cholesterol levels were signifi-
served as controls. cantly higher in nephritic CCR2 knockout mice (356 6
25.8 mg/dL) than in nephritic wild-type mice on day 4
Statistics (239 6 37.1 mg/dL) and day 7, as shown in Figure 3.
Data are given as mean 6 sem. Renal function data, Plasma cholesterol was also increased in wild-type mice
histopathology scores, and immunohistochemistry data given nephrotoxic serum compared with controls.
were analyzed by one-way analysis of variance and Tu- Plasma albumin decreased significantly in nephritic
key’s multiple group comparison test. The null hypothe- wild-type and CCR2 knockout mice compared with con-
sis was rejected at P , 0.05. trols on days 4 and 7, as summarized in Figure 4. This
change in plasma albumin is likely due to increased per-
meability of the GBM and loss of protein in the urine.
RESULTS On day 7, values were significantly lower in nephritic
There was a marked increase in the urinary protein/ knockout mice than in nephritic wild-type animals.
creatinine ratio in nephritic wild-type mice (50 6 6.9) Plasma creatinine levels were not significantly in-
on day 1 compared with control wild-type mice (5 6 creased in nephritic wild-type mice on day 4 (0.4 6 0.02
1.0). These results are summarized in Figure 1. There mg/dL) compared with control wild-type mice (0.4 6
was a significant ameliorative effect of CCR2 knockout 0.02 mg/dL) or nephritic CCR2 knockout mice (0.4 6
on this parameter in nephritic animals on day 1 (35 6 0.04 mg/dL). On day 7, plasma creatinine levels were
3.6). By day 3, protective effects of receptor knockout slightly increased in nephritic wild-type mice (0.5 6 0.08
mg/dL) compared with vehicle-treated, wild-type micewere not observed; the increase in the urinary protein/
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Fig. 4. Effects of CCR2 knockout in nephritic mice on plasma albumin.
Fig. 2. Effects of CCR2 knockout in nephritic mice on blood urea Data are mean 6 sem. *P , 0.05 vs. vehicle wild-type (WT); #P , 0.05
nitrogen. Data are mean 6 sem. *P , 0.05 vs. vehicle wild type (WT); vs. nephritic (NTS) WT. Symbols are: (j) vehicle WT; ( ) vehicle
#P , 0.05 vs. nephritic (NTS) WT. Symbols are: (j) vehicle WT; ( ) knockout (KO); ( ) NTS WT; ( ) NTS KO.
vehicle knockout (KO); ( ) NTS WT; ( ) NTS KO.
Fig. 5. PCR was performed using a pair of primers that amplified a
320 bp fragment of CCR2 (lanes 9 through 15, CCR2 wild-type mice)
and a pair of primers that amplified a 220 bp fragment of the Neo
cassette, included as a positive control (lanes 2 through 8, CCR2 knock-
out mice). As expected, the 320 bp bands representing CCR2 are present
in samples from CCR2 wild-type mice, but absent in samples from
CCR2 knockout mice.
Fig. 3. Effects of CCR2 knockout in nephritic mice on plasma choles-
terol. Data are mean 6 sem. *P , 0.05 vs. vehicle wild-type (WT);
#P , 0.05 vs. nephritic (NTS) WT. Symbols are: (j) vehicle WT; ( )
vehicle knockout (KO); ( ) NTS WT; ( ) NTS KO.
Glomerular injury was significantly more severe in
nephritic CCR2 knockout mice on day 4 (3.1 6 0.3 vs.
2.0 6 0.3) and day 7 (3.6 6 0.2 vs. 2.9 6 0.3) compared
with nephritic wild-type mice (Fig. 6). The most promi-(0.4 6 0.00 mg/dL), but this change failed to reach statis-
tical significance. nent glomerular change was an increase in mesangial
matrix, which ranged from segmental to global in nature.The genotype of CCR2 wild-type and knockout mice
was confirmed by PCR analysis. A representative gel Additional salient glomerular changes, of slightly greater
severity and frequency in nephritic knockout mice, in-is shown in Figure 5. As expected, the 320 bp bands
representing CCR2 are present in samples from wild- cluded mesangial cell hypertrophy and hyperplasia, loss
of capillary lumina, crescent formation and synechia, andtype mice but are absent in samples from CCR2 knock-
out mice. parietal epithelial cell hypertrophy.
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Fig. 6. Glomeruli of vehicle-treated, wild-
type (A) and CCR2 knockout (B) mice were
not remarkable on day 4 (periodic acid-Schiff
stain). Glomerular injury was less severe in
nephritic wild-type mice (C) than in nephritic
CCR2 knockout mice (D). There were more
mac-2–positive cells in the glomeruli of ne-
phritic wild-type mice (E) than CCR2 knock-
out nephritic animals (F; methyl green coun-
terstain). Bar represents 50 mm.
Fig. 7. Generalized, diffuse, linear IgG deposition along glomerular basement membranes, as determined by indirect immunofluorescence, was
similar between nephritic wild-type mice (A) and CCR2 knockout mice (B). Linear immunofluorescence was not present in controls (C). Bar
represents 100 mm.
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The most common extraglomerular change observed Second, other ligands that bind to CCR2, besides
in nephritic mice, with a slightly higher frequency in MCP-1, may be of benefit in nephritis. MCP-3, MCP-4,
knockout mice as compared with wild type, was dilated and MCP-5 are among the known ligands of CCR2
tubules containing variable amounts of proteinaceous [13–15], and it seems unlikely that they exert positive
material, and a rare degenerated neutrophil or sloughed effects in nephritis based on described functions [14–16].
tubular epithelial cells. Prominent resorption droplets For instance, MCP-5 is a potent monocyte active chemo-
were also present in the cytoplasm of proximal tubular kine that is involved in allergic inflammation and the
epithelial cells. Minimal inflammatory infiltrates oc- host response to pathogens [15]. However, there may
curred multifocally in the interstitium; there was no dif- be an as yet unidentified ligand for CCR2 that confers
ference between nephritic wild-type and knockout mice. protection in glomerulonephritis.
Interstitial fibrosis was not a prominent feature of this Third, it has been reported that the severity of glomer-
model at this time. The kidneys of CCR2 wild-type and ulonephritis in mice varies according to the strain. It is
knockout mice treated with heat-inactivated sheep se- important to note that both the wild-type and knockout
rum were not remarkable. mice used in this study are of a hybrid 129/Sv:ICR back-
By immunohistochemical analysis at day 4, there were ground and are derived from crosses of heterozygous
significantly fewer mac-2–positive cells, representative littermates, meaning that they have as close a genetic
of macrophages, in the glomeruli of nephritic CCR2 background as possible. It is extremely unlikely that the
knockout (2.1 6 0.6) mice than nephritic wild-type (3.9 6 differences in renal injury in the wild-type and knockout
0.5) animals (Fig. 6). By day 7, there was no difference mice observed in this study are due to differences in
in the number of mac-2–positive cells within glomeruli their genetic background.
of nephritic wild-type and knockout mice. Finally, another consideration is whether the model
By indirect immunofluorescence, there was a moder- is different from that previously described. The changes
ate, diffuse linear IgG deposition of equivalent severity, in renal function observed in nephritic wild-type mice
present in glomeruli of both wild-type and CCR2 knock- in this study are similar to those reported by other inves-
out nephritic mice (Fig. 7). Immunofluorescence was not tigators. Increased excretion of protein in urine, eleva-
observed in mice treated with heat-inactivated sheep tion of plasma cholesterol and BUN, and a decrease in
serum or in nephritic mice following omission of primary plasma albumin were previously observed in nephritic
antibody. mice [17]. The structural changes of glomerular expan-
sion and crescent formation observed are also similar to
those described previously in rats that received anti-DISCUSSION
GBM antibody [8].The increased severity of disease noted in nephritic
There was an initial benefit of CCR2 knockout onCCR2 knockout mice in this study was an interesting
proteinuria in the very early stages (day 1) of the disease.and unexpected finding, suggesting that a CCR2 gene
This correlates with the observations of other investiga-product may provide an ameliorative effect in nephritis.
tors that glomerular expression of MCP-1 mRNAWe originally postulated that the lack of CCR2, the
peaked between 6 and 24 hours after the induction ofprimary receptor for MCP-1, would reduce macrophage
anti-GBM disease in rats and that monocyte numbersnumber and injury in accelerated nephrotoxic nephritis.
were maximal at 24 hours [8]. These results suggest thatThe macrophage number was reduced in CCR2 knock-
CCR2 and its primary ligand, MCP-1, play an importantout mice as expected, yet increased glomerular injury
role in the acute stages of glomerulonephritis.was observed in nephritic animals. Somewhat similar
Our finding of progression of disease in nephriticresults were reported by other investigators who found
CCR2 knockout mice from partial protection to lack ofmore severe injury in nephritic CCR1 knockout than
effect of receptor knockout is similar to that reportednephritic wild-type mice (abstract; Topham et al, J Am
by Fujinaka et al [8]. In that study, the administrationSoc Nephrol, 9:487A, 1998). There are several possible
of an MCP-1 monoclonal antibody was partially effectiveexplanations for our finding. First, if chemokines are
in abrogating proteinuria on day 4 after administrationinjected systemically, there is eventual downregulation
of nephrotoxic serum and ineffective at day 8 in Wistar-of the response of target leukocytes [12]. This decrease
Kyoto rats. Although the exact time course was differentin target response of leukocytes may be lacking in CCR2
in the two studies, the progression from benefit ofknockout mice, and the absence of downregulation may
anti–MCP-1 treatment to no effect was comparable.lead to enhancement of the immune response and
It may seem surprising that the effects of removinggreater severity of disease. Because of the complexity
the primary receptor for MCP-1 were not more striking,of the chemokine family, it is not unlikely that knockout
but the role of MCP-1 in generating glomerular damageof a chemokine receptor would have significant indirect
effects. may be less important than previously considered. There
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